Mesalazine Industry Research Report 2023

Mesalazine Industry Research Report 2023


This report study Mesalamine API market, Mesalamine API is off white to creamish colored powder. Mesalazine was approved for medical use in the United States in 1987.
Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

Highlights

The global Mesalazine market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The industry's leading manufacturers are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. In terms of regions, the revenue share in Europe is the highest, reaching 43% in 2021, followed by Asia Pacific with a share about 31%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mesalazine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalazine.
The Mesalazine market size, estimations, and forecasts are provided in terms of sales volume (Ton) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Mesalazine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesalazine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical

Product Type Insights

Global markets are presented by Mesalazine type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Mesalazine are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Mesalazine segment by Purity
Above 97 %
Above 98 %
Above 99 %

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Mesalazine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Mesalazine market.
Mesalazine segment by Application

Tablets
Capsules
Pellet and Granule
Suppository
Enema
Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Mesalazine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesalazine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Mesalazine and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Mesalazine industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesalazine.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Mesalazine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Mesalazine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Mesalazine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by purity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Frequently Asked Questions

Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Mesalazine Market Size (2018-2029) & (US$ Million)
2.2.2 Global Mesalazine Sales (2018-2029)
2.2.3 Global Mesalazine Market Average Price (2018-2029)
2.3 Mesalazine by Purity
2.3.1 Market Value Comparison by Purity (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Above 97 %
1.2.3 Above 98 %
1.2.4 Above 99 %
2.4 Mesalazine by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Tablets
2.4.3 Capsules
2.4.4 Pellet and Granule
2.4.5 Suppository
2.4.6 Enema
2.4.7 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Mesalazine Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Mesalazine Sales (Ton) of Manufacturers (2018-2023)
3.3 Global Mesalazine Revenue of Manufacturers (2018-2023)
3.4 Global Mesalazine Average Price by Manufacturers (2018-2023)
3.5 Global Mesalazine Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Mesalazine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Mesalazine, Product Type & Application
3.8 Global Manufacturers of Mesalazine, Date of Enter into This Industry
3.9 Global Mesalazine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 PharmaZell
4.1.1 PharmaZell Company Information
4.1.2 PharmaZell Business Overview
4.1.3 PharmaZell Mesalazine Sales, Revenue and Gross Margin (2018-2023)
4.1.4 PharmaZell Mesalazine Product Portfolio
4.1.5 PharmaZell Recent Developments
4.2 Syntese A/S
4.2.1 Syntese A/S Company Information
4.2.2 Syntese A/S Business Overview
4.2.3 Syntese A/S Mesalazine Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Syntese A/S Mesalazine Product Portfolio
4.2.5 Syntese A/S Recent Developments
4.3 Cambrex Corporation
4.3.1 Cambrex Corporation Company Information
4.3.2 Cambrex Corporation Business Overview
4.3.3 Cambrex Corporation Mesalazine Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Cambrex Corporation Mesalazine Product Portfolio
4.3.5 Cambrex Corporation Recent Developments
4.4 Divis Laboratories
4.4.1 Divis Laboratories Company Information
4.4.2 Divis Laboratories Business Overview
4.4.3 Divis Laboratories Mesalazine Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Divis Laboratories Mesalazine Product Portfolio
4.4.5 Divis Laboratories Recent Developments
4.5 Chemi SpA
4.5.1 Chemi SpA Company Information
4.5.2 Chemi SpA Business Overview
4.5.3 Chemi SpA Mesalazine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Chemi SpA Mesalazine Product Portfolio
6.5.5 Chemi SpA Recent Developments
4.6 Ipca Laboratories
4.6.1 Ipca Laboratories Company Information
4.6.2 Ipca Laboratories Business Overview
4.6.3 Ipca Laboratories Mesalazine Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Ipca Laboratories Mesalazine Product Portfolio
4.6.5 Ipca Laboratories Recent Developments
4.7 Hangzhou Brother
4.7.1 Hangzhou Brother Company Information
4.7.2 Hangzhou Brother Business Overview
4.7.3 Hangzhou Brother Mesalazine Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Hangzhou Brother Mesalazine Product Portfolio
4.7.5 Hangzhou Brother Recent Developments
6.8 Lianyungang Fengheng Biopharm
4.8.1 Lianyungang Fengheng Biopharm Company Information
4.8.2 Lianyungang Fengheng Biopharm Business Overview
4.8.3 Lianyungang Fengheng Biopharm Mesalazine Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Lianyungang Fengheng Biopharm Mesalazine Product Portfolio
4.8.5 Lianyungang Fengheng Biopharm Recent Developments
4.9 Lasa Loboratory
4.9.1 Lasa Loboratory Company Information
4.9.2 Lasa Loboratory Business Overview
4.9.3 Lasa Loboratory Mesalazine Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Lasa Loboratory Mesalazine Product Portfolio
4.9.5 Lasa Loboratory Recent Developments
4.10 Corden Pharma Bergamo
4.10.1 Corden Pharma Bergamo Company Information
4.10.2 Corden Pharma Bergamo Business Overview
4.10.3 Corden Pharma Bergamo Mesalazine Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Corden Pharma Bergamo Mesalazine Product Portfolio
4.10.5 Corden Pharma Bergamo Recent Developments
6.11 Erregierre SpA
6.11.1 Erregierre SpA Company Information
6.11.2 Erregierre SpA Mesalazine Business Overview
6.11.3 Erregierre SpA Mesalazine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Erregierre SpA Mesalazine Product Portfolio
6.11.5 Erregierre SpA Recent Developments
6.12 CTX Lifescience
6.12.1 CTX Lifescience Company Information
6.12.2 CTX Lifescience Mesalazine Business Overview
6.12.3 CTX Lifescience Mesalazine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 CTX Lifescience Mesalazine Product Portfolio
6.12.5 CTX Lifescience Recent Developments
6.13 Ishita Active Pharma Ingredients
6.13.1 Ishita Active Pharma Ingredients Company Information
6.13.2 Ishita Active Pharma Ingredients Mesalazine Business Overview
6.13.3 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Ishita Active Pharma Ingredients Mesalazine Product Portfolio
6.13.5 Ishita Active Pharma Ingredients Recent Developments
6.14 YC Biotech (Jiangsu)
6.14.1 YC Biotech (Jiangsu) Company Information
6.14.2 YC Biotech (Jiangsu) Mesalazine Business Overview
6.14.3 YC Biotech (Jiangsu) Mesalazine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 YC Biotech (Jiangsu) Mesalazine Product Portfolio
6.14.5 YC Biotech (Jiangsu) Recent Developments
6.15 Xinxiang Tianfeng Fine Chemical
6.15.1 Xinxiang Tianfeng Fine Chemical Company Information
6.15.2 Xinxiang Tianfeng Fine Chemical Mesalazine Business Overview
6.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Xinxiang Tianfeng Fine Chemical Mesalazine Product Portfolio
6.15.5 Xinxiang Tianfeng Fine Chemical Recent Developments
5 Global Mesalazine Market Scenario by Region
5.1 Global Mesalazine Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Mesalazine Sales by Region: 2018-2029
5.2.1 Global Mesalazine Sales by Region: 2018-2023
5.2.2 Global Mesalazine Sales by Region: 2024-2029
5.3 Global Mesalazine Revenue by Region: 2018-2029
5.3.1 Global Mesalazine Revenue by Region: 2018-2023
5.3.2 Global Mesalazine Revenue by Region: 2024-2029
5.4 North America Mesalazine Market Facts & Figures by Country
5.4.1 North America Mesalazine Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Mesalazine Sales by Country (2018-2029)
5.4.3 North America Mesalazine Revenue by Country (2018-2029)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Mesalazine Market Facts & Figures by Country
5.5.1 Europe Mesalazine Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Mesalazine Sales by Country (2018-2029)
5.5.3 Europe Mesalazine Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Mesalazine Market Facts & Figures by Country
5.6.1 Asia Pacific Mesalazine Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Mesalazine Sales by Country (2018-2029)
5.6.3 Asia Pacific Mesalazine Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Mesalazine Market Facts & Figures by Country
5.7.1 Latin America Mesalazine Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Mesalazine Sales by Country (2018-2029)
5.7.3 Latin America Mesalazine Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Mesalazine Market Facts & Figures by Country
5.8.1 Middle East and Africa Mesalazine Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Mesalazine Sales by Country (2018-2029)
5.8.3 Middle East and Africa Mesalazine Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Purity
6.1 Global Mesalazine Sales by Purity (2018-2029)
6.1.1 Global Mesalazine Sales by Purity (2018-2029) & (Ton)
6.1.2 Global Mesalazine Sales Market Share by Purity (2018-2029)
6.2 Global Mesalazine Revenue by Purity (2018-2029)
6.2.1 Global Mesalazine Sales by Purity (2018-2029) & (US$ Million)
6.2.2 Global Mesalazine Revenue Market Share by Purity (2018-2029)
6.3 Global Mesalazine Price by Purity (2018-2029)
7 Segment by Application
7.1 Global Mesalazine Sales by Application (2018-2029)
7.1.1 Global Mesalazine Sales by Application (2018-2029) & (Ton)
7.1.2 Global Mesalazine Sales Market Share by Application (2018-2029)
7.2 Global Mesalazine Revenue by Application (2018-2029)
6.2.1 Global Mesalazine Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Mesalazine Revenue Market Share by Application (2018-2029)
7.3 Global Mesalazine Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Mesalazine Value Chain Analysis
8.1.1 Mesalazine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Mesalazine Production Mode & Process
8.2 Mesalazine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Mesalazine Distributors
8.2.3 Mesalazine Customers
9 Global Mesalazine Analyzing Market Dynamics
9.1 Mesalazine Industry Trends
9.2 Mesalazine Industry Drivers
9.3 Mesalazine Industry Opportunities and Challenges
9.4 Mesalazine Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Purity (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Mesalazine Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Mesalazine Sales (Ton) of Manufacturers (2018-2023)
Table 7. Global Mesalazine Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Mesalazine Revenue of Manufacturers (2018-2023)
Table 9. Global Mesalazine Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Mesalazine Average Price (US$/Kg) of Manufacturers (2018-2023)
Table 11. Global Mesalazine Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Mesalazine, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mesalazine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. PharmaZell Company Information
Table 17. PharmaZell Business Overview
Table 18. PharmaZell Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 19. PharmaZell Mesalazine Product Portfolio
Table 20. PharmaZell Recent Developments
Table 21. Syntese A/S Company Information
Table 22. Syntese A/S Business Overview
Table 23. Syntese A/S Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 24. Syntese A/S Mesalazine Product Portfolio
Table 25. Syntese A/S Recent Developments
Table 26. Cambrex Corporation Company Information
Table 27. Cambrex Corporation Business Overview
Table 28. Cambrex Corporation Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 29. Cambrex Corporation Mesalazine Product Portfolio
Table 30. Cambrex Corporation Recent Developments
Table 31. Divis Laboratories Company Information
Table 32. Divis Laboratories Business Overview
Table 33. Divis Laboratories Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 34. Divis Laboratories Mesalazine Product Portfolio
Table 35. Divis Laboratories Recent Developments
Table 36. Chemi SpA Company Information
Table 37. Chemi SpA Business Overview
Table 38. Chemi SpA Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 39. Chemi SpA Mesalazine Product Portfolio
Table 40. Chemi SpA Recent Developments
Table 41. Ipca Laboratories Company Information
Table 42. Ipca Laboratories Business Overview
Table 43. Ipca Laboratories Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 44. Ipca Laboratories Mesalazine Product Portfolio
Table 45. Ipca Laboratories Recent Developments
Table 46. Hangzhou Brother Company Information
Table 47. Hangzhou Brother Business Overview
Table 48. Hangzhou Brother Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 49. Hangzhou Brother Mesalazine Product Portfolio
Table 50. Hangzhou Brother Recent Developments
Table 51. Lianyungang Fengheng Biopharm Company Information
Table 52. Lianyungang Fengheng Biopharm Business Overview
Table 53. Lianyungang Fengheng Biopharm Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 54. Lianyungang Fengheng Biopharm Mesalazine Product Portfolio
Table 55. Lianyungang Fengheng Biopharm Recent Developments
Table 56. Lasa Loboratory Company Information
Table 57. Lasa Loboratory Business Overview
Table 58. Lasa Loboratory Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 59. Lasa Loboratory Mesalazine Product Portfolio
Table 60. Lasa Loboratory Recent Developments
Table 61. Corden Pharma Bergamo Company Information
Table 62. Corden Pharma Bergamo Business Overview
Table 63. Corden Pharma Bergamo Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 64. Corden Pharma Bergamo Mesalazine Product Portfolio
Table 65. Corden Pharma Bergamo Recent Developments
Table 66. Erregierre SpA Company Information
Table 67. Erregierre SpA Business Overview
Table 68. Erregierre SpA Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 69. Erregierre SpA Mesalazine Product Portfolio
Table 70. Erregierre SpA Recent Developments
Table 71. CTX Lifescience Company Information
Table 72. CTX Lifescience Business Overview
Table 73. CTX Lifescience Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 74. CTX Lifescience Mesalazine Product Portfolio
Table 75. CTX Lifescience Recent Developments
Table 76. Ishita Active Pharma Ingredients Company Information
Table 77. Ishita Active Pharma Ingredients Business Overview
Table 78. Ishita Active Pharma Ingredients Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 79. Ishita Active Pharma Ingredients Mesalazine Product Portfolio
Table 80. Ishita Active Pharma Ingredients Recent Developments
Table 81. YC Biotech (Jiangsu) Company Information
Table 82. YC Biotech (Jiangsu) Business Overview
Table 83. YC Biotech (Jiangsu) Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 84. YC Biotech (Jiangsu) Mesalazine Product Portfolio
Table 85. YC Biotech (Jiangsu) Recent Developments
Table 86. Xinxiang Tianfeng Fine Chemical Company Information
Table 87. Xinxiang Tianfeng Fine Chemical Business Overview
Table 88. Xinxiang Tianfeng Fine Chemical Mesalazine Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 89. Xinxiang Tianfeng Fine Chemical Mesalazine Product Portfolio
Table 90. Xinxiang Tianfeng Fine Chemical Recent Developments
Table 91. Global Mesalazine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 92. Global Mesalazine Sales by Region (2018-2023) & (Ton)
Table 93. Global Mesalazine Sales Market Share by Region (2018-2023)
Table 94. Global Mesalazine Sales by Region (2024-2029) & (Ton)
Table 95. Global Mesalazine Sales Market Share by Region (2024-2029)
Table 96. Global Mesalazine Revenue by Region (2018-2023) & (US$ Million)
Table 97. Global Mesalazine Revenue Market Share by Region (2018-2023)
Table 98. Global Mesalazine Revenue by Region (2024-2029) & (US$ Million)
Table 99. Global Mesalazine Revenue Market Share by Region (2024-2029)
Table 100. North America Mesalazine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. North America Mesalazine Sales by Country (2018-2023) & (Ton)
Table 102. North America Mesalazine Sales by Country (2024-2029) & (Ton)
Table 103. North America Mesalazine Revenue by Country (2018-2023) & (US$ Million)
Table 104. North America Mesalazine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Europe Mesalazine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Europe Mesalazine Sales by Country (2018-2023) & (Ton)
Table 107. Europe Mesalazine Sales by Country (2024-2029) & (Ton)
Table 108. Europe Mesalazine Revenue by Country (2018-2023) & (US$ Million)
Table 109. Europe Mesalazine Revenue by Country (2024-2029) & (US$ Million)
Table 110. Asia Pacific Mesalazine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Asia Pacific Mesalazine Sales by Country (2018-2023) & (Ton)
Table 112. Asia Pacific Mesalazine Sales by Country (2024-2029) & (Ton)
Table 113. Asia Pacific Mesalazine Revenue by Country (2018-2023) & (US$ Million)
Table 114. Asia Pacific Mesalazine Revenue by Country (2024-2029) & (US$ Million)
Table 115. Latin America Mesalazine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. Latin America Mesalazine Sales by Country (2018-2023) & (Ton)
Table 117. Latin America Mesalazine Sales by Country (2024-2029) & (Ton)
Table 118. Latin America Mesalazine Revenue by Country (2018-2023) & (US$ Million)
Table 119. Latin America Mesalazine Revenue by Country (2024-2029) & (US$ Million)
Table 120. Middle East and Africa Mesalazine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 121. Middle East and Africa Mesalazine Sales by Country (2018-2023) & (Ton)
Table 122. Middle East and Africa Mesalazine Sales by Country (2024-2029) & (Ton)
Table 123. Middle East and Africa Mesalazine Revenue by Country (2018-2023) & (US$ Million)
Table 124. Middle East and Africa Mesalazine Revenue by Country (2024-2029) & (US$ Million)
Table 125. Global Mesalazine Sales by Purity (2018-2023) & (Ton)
Table 126. Global Mesalazine Sales by Purity (2024-2029) & (Ton)
Table 127. Global Mesalazine Sales Market Share by Purity (2018-2023)
Table 128. Global Mesalazine Sales Market Share by Purity (2024-2029)
Table 129. Global Mesalazine Revenue by Purity (2018-2023) & (US$ Million)
Table 130. Global Mesalazine Revenue by Purity (2024-2029) & (US$ Million)
Table 131. Global Mesalazine Revenue Market Share by Purity (2018-2023)
Table 132. Global Mesalazine Revenue Market Share by Purity (2024-2029)
Table 133. Global Mesalazine Price by Purity (2018-2023) & (US$/Kg)
Table 134. Global Mesalazine Price by Purity (2024-2029) & (US$/Kg)
Table 135. Global Mesalazine Sales by Application (2018-2023) & (Ton)
Table 136. Global Mesalazine Sales by Application (2024-2029) & (Ton)
Table 137. Global Mesalazine Sales Market Share by Application (2018-2023)
Table 138. Global Mesalazine Sales Market Share by Application (2024-2029)
Table 139. Global Mesalazine Revenue by Application (2018-2023) & (US$ Million)
Table 140. Global Mesalazine Revenue by Application (2024-2029) & (US$ Million)
Table 141. Global Mesalazine Revenue Market Share by Application (2018-2023)
Table 142. Global Mesalazine Revenue Market Share by Application (2024-2029)
Table 143. Global Mesalazine Price by Application (2018-2023) & (US$/Kg)
Table 144. Global Mesalazine Price by Application (2024-2029) & (US$/Kg)
Table 145. Key Raw Materials
Table 146. Raw Materials Key Suppliers
Table 147. Mesalazine Distributors List
Table 148. Mesalazine Customers List
Table 149. Mesalazine Industry Trends
Table 150. Mesalazine Industry Drivers
Table 151. Mesalazine Industry Restraints
Table 152. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. MesalazineProduct Picture
Figure 5. Global Mesalazine Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Mesalazine Market Size (2018-2029) & (US$ Million)
Figure 7. Global Mesalazine Sales (2018-2029) & (Ton)
Figure 8. Global Mesalazine Average Price (US$/Kg) & (2018-2029)
Figure 9. Above 97 % Product Picture
Figure 10. Above 98 % Product Picture
Figure 11. Above 99 % Product Picture
Figure 12. Tablets Product Picture
Figure 13. Capsules Product Picture
Figure 14. Pellet and Granule Product Picture
Figure 15. Suppository Product Picture
Figure 16. Enema Product Picture
Figure 17. Others Product Picture
Figure 18. Global Mesalazine Revenue Share by Manufacturers in 2022
Figure 19. Global Manufacturers of Mesalazine, Manufacturing Sites & Headquarters
Figure 20. Global Manufacturers of Mesalazine, Date of Enter into This Industry
Figure 21. Global Top 5 and 10 Mesalazine Players Market Share by Revenue in 2022
Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. Global Mesalazine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. Global Mesalazine Sales by Region in 2022
Figure 25. Global Mesalazine Revenue by Region in 2022
Figure 26. North America Mesalazine Market Size by Country in 2022
Figure 27. North America Mesalazine Sales Market Share by Country (2018-2029)
Figure 28. North America Mesalazine Revenue Market Share by Country (2018-2029)
Figure 29. U.S. Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Canada Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Europe Mesalazine Market Size by Country in 2022
Figure 32. Europe Mesalazine Sales Market Share by Country (2018-2029)
Figure 33. Europe Mesalazine Revenue Market Share by Country (2018-2029)
Figure 34. Germany Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. France Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. U.K. Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Italy Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Russia Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Asia Pacific Mesalazine Market Size by Country in 2022
Figure 40. Asia Pacific Mesalazine Sales Market Share by Country (2018-2029)
Figure 41. Asia Pacific Mesalazine Revenue Market Share by Country (2018-2029)
Figure 42. China Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Japan Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. South Korea Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. India Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Australia Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. China Taiwan Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Indonesia Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Thailand Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Malaysia Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Latin America Mesalazine Market Size by Country in 2022
Figure 52. Latin America Mesalazine Sales Market Share by Country (2018-2029)
Figure 53. Latin America Mesalazine Revenue Market Share by Country (2018-2029)
Figure 54. Mexico Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Brazil Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Argentina Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Middle East and Africa Mesalazine Market Size by Country in 2022
Figure 58. Middle East and Africa Mesalazine Sales Market Share by Country (2018-2029)
Figure 59. Middle East and Africa Mesalazine Revenue Market Share by Country (2018-2029)
Figure 60. Turkey Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 61. Saudi Arabia Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 62. UAE Mesalazine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 63. Global Mesalazine Sales Market Share by Purity (2018-2029)
Figure 64. Global Mesalazine Revenue Market Share by Purity (2018-2029)
Figure 65. Global Mesalazine Price (US$/Kg) by Purity (2018-2029)
Figure 66. Global Mesalazine Sales Market Share by Application (2018-2029)
Figure 67. Global Mesalazine Revenue Market Share by Application (2018-2029)
Figure 68. Global Mesalazine Price (US$/Kg) by Application (2018-2029)
Figure 69. Mesalazine Value Chain
Figure 70. Mesalazine Production Mode & Process
Figure 71. Direct Comparison with Distribution Share
Figure 72. Distributors Profiles
Figure 73. Mesalazine Industry Opportunities and Challenges

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings